Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

PURPOSE: We and others have reported that adding adefovir dipivoxil (adefovir) to lamivudine results in virological and biochemical improvement in cases of lamivudine resistance. The current study assessed the efficacy and safety of combined therapy after 104 weeks of combined treatment and analyzed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Perrillo, Robert P., Hann, Hie-Won, Schiff, Eugene, Mutimer, David, Willems, Bernard, Leung, Nancy, Lee, William M., Dixon, Susan, Woessner, Mary, Brosgart, Carol L., Condreay, Lynn D., Gardner, Stephen D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090563/
https://ncbi.nlm.nih.gov/pubmed/21484148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9228-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak